K8凯发(中国)

Adenovirus (ADV) Vectors

Adenovirus (ADV) Vectors

Adenovirus (ADV) is a non-enveloped, linear, double-stranded DNA virus with broad-spectrum cellular and tissue infectivity. Its infection process is vigorous, making it suitable for experiments involving high gene expression in a short time. Compared to other viruses, adenovirus has the advantage of longer insertion fragments and stronger expression activity. In vitro, adenovirus vectors exhibit high transduction efficiency (nearly 100%) and can transduce different cell types, making it an excellent tool for gene delivery to large numbers of difficult-to-transfect cells. However, in vivo, due to the strong immunogenicity and vigorous infection of adenovirus, it often induces local tissue inflammation and immune responses in animals, affecting the objectivity of animal signs and experimental results.
Description

Overview

Adenovirus  (ADV)is a non-enveloped, linear, double-stranded DNA virus with broad-spectrum cellular and tissue infectivity. Its infection process is vigorous, making it suitable for experiments involving high gene expression in a short time. Compared to other viruses, adenovirus has the advantage of longer insertion fragments and stronger expression activity. In vitro, adenovirusvectorsexhibit high transduction efficiency (nearly 100%) and can transduce different cell types, making it an excellent tool for gene delivery to large numbers of difficult-to-transfect cells. However, in vivo, due to the strong immunogenicity and vigorous infection of adenovirus, it often induces local tissue inflammation and immune responses in animals, affecting the objectivity of animal signs and experimental results.


About Us
Scan to follow our latest newsScan to follow our latest news
Contact Us
400-800-1266

Working hours: Monday to Friday, 9:00-18:00

Contact:Ms. Lai

Email:laijiaqi@61zoeshop.com

Address:No. 1, Rongtian Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen, China (Hepure Biomedical Ecological Park)

Cell Valley Group is a leading CGT infrastructure platform in China. We capitalize on the strategic window opened by Decree No. 818 to bridge the gap between clinical research and commercialization.

We pioneer the "Hospital to Industry" (H2I) model. Basically, we act as the core partner for hospitals, providing a one-stop solution for new biomedical tech—covering process development, GMP manufacturing, QC, and commercial rollout. Our mission is to push China's CGT sector from pure R&D into a standardized, scalable industry.
 Copyright 粤ICP备2024168379号 互联网药品信息服务资格证书:(粤)-非经营性-2022-0426  Technical Support:YouDian Software